{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:06:04Z","timestamp":1789653964644,"version":"4.0.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.psc.2016.04.009","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T22:02:47Z","timestamp":1466892167000},"page":"487-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Adverse Effects of Psychotropic Medications on Sleep"],"prefix":"10.1016","volume":"39","author":[{"given":"Karl","family":"Doghramji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Jangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.psc.2016.04.009_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archpsyc.1992.01820080059010","article-title":"Sleep and psychiatric disorders. A meta-analysis","volume":"49","author":"Benca","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2016.04.009_bib2","series-title":"Antidepressant Use in Persons Aged 12 and Over: United States, 2005\u20132008","author":"Pratt","year":"2011"},{"issue":"7063","key":"10.1016\/j.psc.2016.04.009_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0748730406294627","article-title":"Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback","volume":"21","author":"Fuller","year":"2006","journal-title":"J\u00a0Biol Rhythms"},{"key":"10.1016\/j.psc.2016.04.009_bib5","series-title":"The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 2.2","author":"Berry","year":"2015"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-199210000-00006","article-title":"Fluoxetine: activating and sedating effects at multiple fixed doses","volume":"12","author":"Beasley","year":"1992","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/npp.1994.14","article-title":"The effects of nefazodone on sleep architecture in depression","volume":"10","author":"Armitage","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2016.04.009_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004850-199010000-00002","article-title":"Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables","volume":"5","author":"Kerkhofs","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/npp.1994.10","article-title":"The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study","volume":"10","author":"Hendrickse","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v58n0502","article-title":"A\u00a0comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial","volume":"58","author":"Gillin","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0893-133X(98)00131-6","article-title":"Effects of fluoxetine on the polysomnogram in outpatients with major depression","volume":"20","author":"Trivedi","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0006-3223(91)90097-6","article-title":"Effect of fluoxetine on sleep","volume":"29","author":"Keck","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/sleep\/15.3.226","article-title":"Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder","volume":"15","author":"Schenck","year":"1992","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0893-133X(95)00148-7","article-title":"Fluoxetine-induced sleep disturbance in depressed patients","volume":"14","author":"Dorsey","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-199409000-00009","article-title":"The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers","volume":"9","author":"Vasar","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.psc.2016.04.009_bib16","first-page":"637","article-title":"A\u00a0double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression","volume":"32","author":"Luthringer","year":"1996","journal-title":"Psychopharmacol Bull"},{"issue":"8","key":"10.1016\/j.psc.2016.04.009_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4088\/JCP.v58n0803","article-title":"Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers","volume":"58","author":"Salin-Pascual","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.psc.2016.04.009_bib18","first-page":"S37","article-title":"Effects of trazodone on the sleep of depressed subjects\u2013a polygraphic study","volume":"95","author":"Mouret","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psc.2016.04.009_bib19","series-title":"Remeron\u2014a novel pharmacological treatment for depression","author":"Organon, Inc","year":"1996"},{"issue":"9207","key":"10.1016\/j.psc.2016.04.009_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2005-864120","article-title":"Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice","volume":"38","author":"Grasmader","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-3223(00)00882-9","article-title":"Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study","volume":"48","author":"Winokur","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2016.04.009_bib23","series-title":"Product information REMERON oral tablets, mirtazapine tablets","author":"Organon USA","year":"2007"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1176\/ajp.152.2.274","article-title":"REM sleep enhancement by bupropion in depressed men","volume":"152","author":"Nofzinger","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2016.04.009_bib25","series-title":"Product information for FETZIMA (levomilnacipran) extended-release capsules","author":"Forest Pharmaceuticals USA, Inc","year":"2013"},{"key":"10.1016\/j.psc.2016.04.009_bib26","series-title":"Product information for VIIBRYD (vilazodone hydrochloride) tablets","author":"Forest Pharmaceuticals USA, Inc","year":"2015"},{"key":"10.1016\/j.psc.2016.04.009_bib27","series-title":"Product information for BRINTELLIX (vortioxetine) tablets","author":"Takeda Pharmaceuticals America, Inc","year":"2013"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib28","first-page":"535","article-title":"Nortriptyline and EEG sleep in depressed patients","volume":"17","author":"Kupfer","year":"1982","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/clpt.1984.171","article-title":"Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients","volume":"36","author":"Shipley","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/sleep\/12.6.537","article-title":"Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients","volume":"12","author":"Ware","year":"1989","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0006-3223(91)90208-4","article-title":"Fluvoxamine versus desipramine: Comparative polysomnographic effects","volume":"29","author":"Kupfer","year":"1991","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2016.04.009_bib32","first-page":"67","article-title":"Doxepin for insomnia","volume":"9","author":"Markov","year":"2010","journal-title":"Curr Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2016.04.009_bib33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1\u00a0mg, 3\u00a0mg, and 6\u00a0mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.psc.2016.04.009_bib34","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1\u00a0mg, 3\u00a0mg, and 6\u00a0mg in elderly patients with primary insomnia: a randomized, double-blind, placebo controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0149-7634(05)80159-9","article-title":"Drug effects on REM sleep and on endogenous depression","volume":"14","author":"Vogel","year":"1990","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0022-006X.62.1.83","article-title":"Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy","volume":"62","author":"Nofzinger","year":"1994","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-3223(94)00135-P","article-title":"Effect of pharmacologic treatments on the sleep of depressed patients","volume":"37","author":"Sharpley","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2016.04.009_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0006-3223(96)00424-6","article-title":"Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation","volume":"42","author":"Reynolds","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib39","first-page":"41","article-title":"EEG sleep measures in later-life bereavement depression. A randomized, double-blind, placebo-controlled evaluation of nortriptyline","volume":"7","author":"Taylor","year":"1999","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archpsyc.1971.01750080049007","article-title":"Total prolonged drug-induced REM sleep suppression in anxious-depressed patients","volume":"24","author":"Wyatt","year":"1971","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00422798","article-title":"REM sleep and central monoamine oxidase inhibition","volume":"27","author":"Kupfer","year":"1972","journal-title":"Psychopharmacologia"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1192\/S000712500029750X","article-title":"Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients","author":"Monti","year":"1989","journal-title":"Br J Psychiatry Suppl"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-3956(96)00022-2","article-title":"The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs","volume":"30","author":"Wetter","year":"1996","journal-title":"J\u00a0Psychiatr Res"},{"issue":"4","key":"10.1016\/j.psc.2016.04.009_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(96)00347-2","article-title":"Effects of clozapine on sleep: a longitudinal study","volume":"42","author":"Hinze-Selch","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00571411","article-title":"A\u00a0psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults","volume":"56","author":"Touyz","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psc.2016.04.009_bib46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1017\/S1092852900017089","article-title":"Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"issue":"8","key":"10.1016\/j.psc.2016.04.009_bib47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4088\/JCP.09r05535gre","article-title":"Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics","volume":"72","author":"Gao","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-007-0968-8","article-title":"Quetiapine in primary insomnia: a pilot study","volume":"196","author":"Wiegand","year":"2008","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.psc.2016.04.009_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jcp.0000169624.37819.60","article-title":"Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study","volume":"25","author":"Robert","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/YIC.0b013e3282f39703","article-title":"Effects of antipsychotic medications on sleep in schizophrenia","volume":"23","author":"Krystal","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.psc.2016.04.009_bib51","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.pnpbp.2004.05.048","article-title":"Effects of clozapine on sleep in bipolar and schizoaffective disorders","volume":"28","author":"Armitage","year":"2004","journal-title":"Prog NeuroPsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2016.04.009_bib52","first-page":"333","article-title":"Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study","volume":"24","author":"Dursun","year":"1999","journal-title":"J\u00a0Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/YIC.0b013e3281c55f4f","article-title":"A\u00a0double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia","volume":"22","author":"Luthringer","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.psc.2016.04.009_bib54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0006-3223(99)00273-5","article-title":"Olanzapine increases slow-wave sleep: Evidence for blockade of central 5-HT(2C) receptors in\u00a0vivo","volume":"47","author":"Sharpley","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-3223(98)00372-2","article-title":"Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency","volume":"46","author":"Salin-Pascual","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2016.04.009_bib56","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S1461145712001599","article-title":"Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature","volume":"16","author":"Rittmannsberger","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.psc.2016.04.009_bib57","series-title":"Product information for SEROQUEL (quetiapine fumarate) tablets","author":"AstraZeneca Pharmaceuticals LP","year":"2009"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpsychires.2008.02.006","article-title":"Restless legs syndrome as side effect of second generation antidepressants","volume":"43","author":"Rottach","year":"2008","journal-title":"J\u00a0Psychiatr Res"},{"issue":"7","key":"10.1016\/j.psc.2016.04.009_bib59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mds.22517","article-title":"Gender differences in the association between antidepressant use and restless legs syndrome","volume":"24","author":"Baughman","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.psc.2016.04.009_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.genhosppsych.2006.10.006","article-title":"Restless legs syndrome induced by citalopram: a psychiatric emergency?","volume":"29","author":"Perroud","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wnf.0000194706.61224.29","article-title":"Bupropion may improve restless legs syndrome: a report of three cases","volume":"28","author":"Kim","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"10.1016\/j.psc.2016.04.009_bib62","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.v69n0904","article-title":"Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study","volume":"69","author":"Lam","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2016.04.009_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/cap.1999.9.157","article-title":"Unravelling sleep problems in treated and untreated children with ADHD","volume":"9","author":"Stein","year":"1999","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psc.2016.04.009_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/cap.2010.0095","article-title":"Adverse events in medication treatment-naive children with attention-deficit\/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate","volume":"22","author":"Wigal","year":"2012","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.psc.2016.04.009_bib65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-7138(09)60668-3","article-title":"The effects of nocturnally administered stimulant medication on EEG sleep and behavior in hyperactive children","volume":"22","author":"Chatoor","year":"1983","journal-title":"J\u00a0Am Acad Child Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2016.04.009_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2006.03.004","article-title":"Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies","volume":"10","author":"Sadeh","year":"2006","journal-title":"Sleep Med Rev"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X1630020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X1630020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T06:04:26Z","timestamp":1568095466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X1630020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0193953X1630020X"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2016.04.009","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Effects of Psychotropic Medications on Sleep","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2016.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}